Gastrointestinal Stromal Tumors

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)

Completed
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +34 more
Nov 17, 2022

Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic Trial in France (Imatinib maintenance)

Recruiting
  • Gastrointestinal Stromal Tumors
  • +4 more
  • Imatinib maintenance
  • Marseille, Bouches Du Rhône, France
  • +16 more
Jul 28, 2021

Soft-tissue Sarcoma, Gastrointestinal Stromal Tumors, Bone Sarcoma Trial in Worldwide (Quality assessment)

Unknown status
  • Soft-tissue Sarcoma
  • +2 more
  • Quality assessment
  • Buenos Aires, Argentina
  • +8 more
Feb 9, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Sunitinib)

Unknown status
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +120 more
Jan 4, 2021

Gastrointestinal Stromal Tumors Trial in France, Italy, Spain (regorafenib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Bordeaux, France
  • +16 more
Dec 18, 2019

Gastrointestinal Stromal Tumors Trial in France, Lebanon, United States (Masitinib, Imatinib)

Terminated
  • Gastrointestinal Stromal Tumors
  • Orlando, Florida
  • +42 more
Dec 2, 2019

Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • Best Supportive Care (BSC) +/- imatinib or sunitinib
  • Los Angeles, California
  • +34 more
Jun 5, 2012